Bioverativ Launches as Global Biotechnology Company Dedicated to Meaningful Progress in Hemophilia
WALTHAM, Mass.–(BUSINESS WIRE)– Today , Bioverativ Inc. (NASDAQ: BIVVV) launches as an independent, global biotechnology company focused on the discovery, development, and commercialization of innovative...